Peer-reviewedCC BYPharmacology research & perspectives
Investigating the Effect of Lapatinib on the Performance of Sonodynamic Therapy Against Prostate Cancer via Inhibition of the ABCG2 Efflux System
- 1University College London
Related
- Synthesis of Curcumin Analogs Targeting Androgen Receptor for the Selective Inhibition of Castration‐Resistant Prostate Cancer Cells
- Dual inhibition of p38α MAPK and Casein kinase δ/ϵ as a novel treatment strategy for AR-independent and taxane-resistant advanced prostate cancer
- Profiling Siglec-7 and Siglec-9 ligands across the LuCaP PDX series: Implications for glyco-immune checkpoint inhibition in advanced prostate cancer
- Biparametric Prostate MRI: Diagnostic Performance, Estimated Additional Cost of DCE, and Gadolinium Avoidance
- HDAC6 inhibition reverts docetaxel resistance in castration resistant prostate cancer
BibTeX
@article{wang2026investigating,
title = {{Investigating the Effect of Lapatinib on the Performance of Sonodynamic Therapy Against Prostate Cancer via Inhibition of the ABCG2 Efflux System}},
author = {Yidong Wang and Hamzah Masood and Nikolitsa Nomikou},
journal = {Pharmacology research \& perspectives},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13691173},
note = {CC BY},
}
RIS
TY - JOUR
TI - Investigating the Effect of Lapatinib on the Performance of Sonodynamic Therapy Against Prostate Cancer via Inhibition of the ABCG2 Efflux System
AU - Yidong Wang
AU - Hamzah Masood
AU - Nikolitsa Nomikou
PY - 2026
DA - 2026/10/22
JO - Pharmacology research & perspectives
UR - https://europepmc.org/article/PMC/PMC13691173
SN - 2052-1707
ER -